Periodic Reporting for period 4 - ANTHEM (ANTHEM: A Novel Tolerogenic vaccine for the treatment of antibodies in HaEMophilia)

This project has significantly advanced the development of IN-3012, a novel tolerogenic vaccine that utilizes a person’s own cells to treat neutralizing antibodies (NA) in Haemophilia A patients who have failed immune tolerance induction (ITI). Haemophilia A patients are...